The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer

Xuelu Li, Chen Song, Gena Huang, Siwen Sun, Jingjing Qiao, Jinbo Zhao, Zuowei Zhao, Man Li

Open source

DOI
10.2147/ott.s132806
Published
2017-03
Container
OncoTargets and Therapy
Publisher
Informa UK Limited
Open access
unknown

Credibility signals

serious concern Score 29/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ott.s132806,
  title = {The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer},
  author = {Xuelu Li and Chen Song and Gena Huang and Siwen Sun and Jingjing Qiao and Jinbo Zhao and Zuowei Zhao and Man Li},
  year = {2017},
  journal = {OncoTargets and Therapy},
  doi = {10.2147/ott.s132806},
  url = {https://doi.org/10.2147/ott.s132806}
}

RIS

TY  - JOUR
TI  - The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer
AU  - Xuelu Li
AU  - Chen Song
AU  - Gena Huang
AU  - Siwen Sun
AU  - Jingjing Qiao
AU  - Jinbo Zhao
AU  - Zuowei Zhao
AU  - Man Li
PY  - 2017
JO  - OncoTargets and Therapy
DO  - 10.2147/ott.s132806
UR  - https://doi.org/10.2147/ott.s132806
ER  - 

APA

Li, X., Song, C., Huang, G., Sun, S., Qiao, J., Zhao, J., Zhao, Z., & Li, M. (2017). The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer. OncoTargets and Therapy. https://doi.org/10.2147/ott.s132806

Source records